Cambridge A-Level Biology: Infectious Disease – Malaria (Causes, Transmission & Control)
Table of Contents
- Introduction to Malaria
- Disease Profile: Pathogen vs. Vector
- Modes of Transmission
- Biological Vector Transmission
- Alternative Transmission Routes
- The Life Cycle of Plasmodium inside the Human Host
- The Liver Stage (Hepatocytes)
- The RBC Stage (Erythrocytes & Symptoms)
- Prevention and Control Strategies
- Targeting the Vector (Anopheles)
- Disrupting Human-Vector Contact
- Prophylaxis and Anti-Malarial Treatment
- Cambridge Exam Focus: Why is Malaria Control So Difficult?
- Antigenic Variation Explained
- Eukaryotic Complexity & Resistance Issues
- AO1 Knowledge with Understanding (Direct & Recall Questions)
- AO2 Application of Knowledge (Diagram & Labeling Questions)
- AO3 Experimental Skills & Data Interpretation (Graph & Table Questions)
Introduction to Malaria
- Malaria is a significant global infectious disease primarily prevalent in tropical and subtropical regions.
- Depending on the geographical location and transmission rates, it is classified as an endemic disease in many parts of the world, posing a major global health and biological challenge.
- Malaria is caused by a unicellular eukaryotic parasite belonging to the kingdom Protoctist, specifically from the genus Plasmodium.
- The parasite is digenetic, meaning it requires two distinct hosts to complete its life cycle:
- Primary Host / Vector is Female Anopheles Mosquito Which acts as the biological vehicle that transmits the pathogen from one human to another.
- Secondary Host is human Where the parasite undergoes asexual reproduction.
- Different species of the Plasmodium genus cause varying forms of malaria, characterized by the frequency and severity of the recurrent fever:
- It is Caused by Plasmodium vivax.
- It is widely distributed across tropical and subtropical regions, where fever recurs every 48 hours.
- It is Caused by Plasmodium malariae. It is characterized by a 72-hour fever cycle.
- It is Caused by Plasmodium ovale,
- It is predominantly found in West Africa and parts of South America.
- It is Caused by Plasmodium falciparum.
- This is the most severe, fatal, and clinically dangerous form of malaria, often referred to as pernicious malaria.
- In the Cambridge examination, you must clearly distinguish between the causative agent and the vector.
- Name of the Disease: Malaria
- Causative Agent (Pathogen): Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale.
- Vector (Transmission Agent): Female Anopheles mosquito.
- The transmission of the Plasmodium parasite relies heavily on its biological vector, but alternative pathways also exist where direct blood-to-blood contact occurs.
- This is the primary and most common route of malaria transmission.
- It is an active biological process involving the vector and the human host.
- The female Anopheles mosquito acts as the biological vector.
- When an infected female Anopheles mosquito bites a human to take a blood meal, it punctures the skin and reaches a capillary.
- Before sucking blood, it injects its saliva directly into the human host's bloodstream.
- The mosquito's saliva contains specialized anticoagulants that prevent the human blood from clotting inside its proboscis (feeding tube).
- Along with the saliva, the mosquito inadvertently injects the infective, motile stage of the parasite, known as sporozoites, into the human circulatory system.
- From here, the sporozoites quickly migrate to the liver within 30 minutes.
- While vector transmission is responsible for the vast majority of cases, Plasmodium can be transmitted whenever infected red blood cells (erythrocytes) from one individual enter the bloodstream of another.
- These routes bypass the mosquito stage entirely:
- Blood Transfusions: Receiving blood from an infected donor who carries the erythrocytic (RBC) stage of the parasite.
- Intravenous (IV) Needle Sharing: The use of unsterilized, shared hypodermic needles among intravenous drug users can mechanically transfer infected blood from person to person.
- Congenital (Vertical) Transmission: An infected pregnant mother can pass the parasite across the placental barrier directly to her unborn fetus (transplacental transmission), or the baby can become infected during childbirth through blood contact.
- The life cycle of Plasmodium is alternating and complex, requiring two hosts: the human (where it reproduces asexually) and the female Anopheles mosquito (where it reproduces sexually).
- To make asexual phase simple for my cambridge students , this phase has been splitted into various stages .
- When an infected female Anopheles mosquito bites a healthy human, it introduces the infective stage, called sporozoites, into the bloodstream.
- Each sporozoite is a motile, single-nucleated cell covered by a protective elastic Cuticle.
- Within 30 minutes, these sporozoites leave the bloodstream and enter the liver cells (hepatocytes).
- Inside the liver, the parasite undergoes an asexual reproduction process called schizogony.
- Initially, they form cryptozoites, which multiply to produce thousands of crypto-merozoites.
- These enter fresh liver cells to further develop into meta-crypto-merozoites and micro-crypto-merozoites.
- The micro-crypto-merozoites burst out of the liver cells, enter the bloodstream, and actively target the Red Blood Cells (erythrocytes).
- Inside the RBC, the parasite assumes a disc-like shape with a large central vacuole, pushing the nucleus to the periphery.
- This gives it a classic signet ring appearance under a microscope.
- The parasite begins to feed actively on the host's hemoglobin, growing into a flexible, moving trophozoite stage.
- The mature trophozoite develops into a schizont. The schizont undergoes erythrocytic schizogony, losing its pseudopodia, and its nucleus divides to form a cluster of new merozoites (resembling a flower, known as the rosette stage).
- After several cycles of infecting fresh RBCs, some merozoites stop dividing asexually and differentiate into sexual forms called gametocytes.
- Macrogametocyte are the large female gametocyte. whereas Microgametocytes are smaller, male gametocyte.
๐ Sporozoites enter via mosquito saliva.
⬇️
๐ Liver Cells (Hepatocytes): Multiply to form Crypto-merozoites.
⬇️
๐ Red Blood Cells (RBCs): Signet Ring → Trophozoite → Schizont.
⬇️
๐ Bursting: Releases Merozoites & Hemozoin (causes fever).
⬇️
๐ Differences: Turns into Male & Female Gametocytes.
- When a female Anopheles mosquito bites an infected malaria patient, it sucks up the blood meal containing these macro and microgametocytes into its stomach (gut).
- Inside the mosquito's stomach, the male and female gametocytes develop further and fuse (fertilization), forming a diploid zygote.
- After a period of rest, the zygote transforms into an elongated, motile stage called an ookinete.
- The ookinete penetrates the stomach wall of the mosquito and covers itself with a protective layer, turning into an oocyst (encysted stage).
- Inside the oocyst, the parasite undergoes asexual multiplication called sporogony.
- The nucleus divides repeatedly, producing thousands of slender, infectious sporozoites.
- Once the oocyst bursts, these sporozoites are liberated into the mosquito's body cavity (hemocoel) and travel directly to the salivary glands, where they are stored.
- When this mosquito bites another healthy person, the stored sporozoites are injected into the new host along with its saliva, ready to begin the next life cycle.
Sexual Phase of Plasmodium
๐ Ingestion: Mosquito sucks blood with Gametocytes.
⬇️
๐ Mosquito Gut (Stomach): Gametes fuse to form a diploid Zygote.
⬇️
๐ Ookinete Stage: Zygote becomes motile, bores into stomach wall.
⬇️
๐ Oocyst & Sporogony: Divides asexually to create thousands of Sporozoites.
⬇️
๐ Salivary Glands: Oocyst bursts; sporozoites migrate to glands for next bite.
- Malaria control programs operate on three main levels: eliminating the vector, preventing the vector from reaching humans, and using medical treatment to clear the parasite.
- The most effective way to stop malaria is to break the life cycle of the female Anopheles mosquito, particularly during its aquatic stages (Eggs, Larva, Pupa).
- It may be achieved by the following measures :
- Spraying oil or kerosene over standing water surfaces.
- The oil forms a thin film that clogs the breathing tubes (spiracles) of mosquito larvae and pupae, suffocating them.
- Introducing larvivorous fish, such as Gambusia affinis (Mosquito fish), into ponds, paddy fields, and drainage systems.
- These fish actively feed on mosquito larvae, reducing the adult population naturally without chemicals.
- Spraying residual insecticides (like pyrethroids or older compounds like DDT) on indoor walls where mosquitoes rest after feeding.
Disrupting Human-Vector Contact
- If the vector cannot be eliminated, the next line of defense is to physically prevent the infected mosquito from biting a human host.
- Sleeping under bed nets treated with synthetic pyrethroid insecticides.
- This provides a dual layer of protection—a physical barrier and a chemical deterrent that kills the mosquito upon contact.
- Fitting windows and doors with fine wire mesh to prevent mosquitoes from entering residential houses, especially during dusk and dawn when Anopheles is most active.
- Applying formulations containing DEET (Diethyltoluamide) on exposed skin or wearing long-sleeved clothing to mask human scents (carbon dioxide and lactic acid) that attract mosquitoes.
- When a person travels to an endemic region or is already infected, medical protocols are used to target the Plasmodium parasite inside the person.
- Taking preventative anti-malarial drugs before, during, and after traveling to a malaria-prone area.
- Drugs like chloroquine, doxycycline, or mefloquine are taken to kill any parasite that enters the bloodstream before it can establish a severe infection.
- For confirmed malaria cases, Artemisinin-based Combination Therapy (ACT) is the global gold standard recommended by the WHO uses a combination of two different drugs to rapidly clear parasites from the blood.
- Despite decades of global effort, eradicating malaria remains one of the greatest challenges in modern medicine.
- The primary reasons lie within the genetic and structural complexity of the Plasmodium parasite itself.
- One of the main reasons our immune system fails to clear Plasmodium naturally and why making an effective vaccine is so difficult is Antigenic Variation.
- What are Antigens? The surface of the Plasmodium parasite is covered with specific proteins (antigens) that our immune system (B-lymphocytes) recognizes to produce specific antibodies.
- The Parasite's Strategy: Plasmodium possesses a large family of surface protein genes (such as the var genes in P. falciparum). It does not express all these genes at once. Instead, it constantly switches which surface protein it presents to the host's immune system.
- Immune Evasion: By the time the human body mounts a successful primary immune response and produces antibodies against one specific surface antigen, the parasite has already switched its genetic expression to display a completely different antigen.
- The Result: The existing antibodies become useless. The immune system has to start the recognition process all over again from scratch. This allows the parasite to multiply unchecked and establish a chronic, long-term infection.
- Unlike bacteria or viruses, Plasmodium is a highly evolved, multi-stage Eukaryotic organism, which creates severe clinical and biochemical challenges.
- Being a eukaryote, Plasmodium has a much larger genome and a more complex cellular structure than bacteria.
- It has thousands of genes, giving it multiple metabolic pathways and redundant survival mechanisms.
- The parasite constantly changes its morphology (form) and habitat within the same host.
- It moves from liver cells (intracellular) to the bloodstream (extracellular) and then hides inside Red Blood Cells (intracellular).
- A drug or vaccine that targets the liver stage (sporozoites) is completely ineffective against the blood stage (merozoites).
- Because Plasmodium is eukaryotic, its cellular machinery (ribosomes, enzymes, and metabolic pathways) is highly similar to human cells.
- Designing a drug that is toxic enough to kill the parasite but safe enough not to harm the human host is extremely difficult.
- Due to its genetic flexibility, Plasmodium rapidly undergoes mutations under selection pressure. It has developed widespread resistance to traditional, cheap anti-malarial drugs like chloroquine and proguanil.
- Now, emerging resistance against the frontline drug Artemisinin poses a massive global threat.
- To make matters worse, the eukaryotic complexity isn't limited to the parasite.
- The mosquito vector (Anopheles) also undergoes natural selection and has developed widespread resistance to the insecticides (like DDT and pyrethroids) used in bed nets and indoor spraying.
| Stage Micrometer Divisions (Each division = 10 ฮผm) | Eyepiece Graticule Units (epu) | Calculation for 1 epu | Actual Value of 1 epu (ฮผm) |
|---|---|---|---|
| 4 divisions (= 40 ฮผm) | 16 epu | 40 ฮผm / 16 epu | 2.5 ฮผm |
| 8 divisions (= 80 ฮผm) | 32 epu | 80 ฮผm / 32 epu | 2.5 ฮผm |
| Concentration of Drug X (nmol dm⁻³) | Percentage of Surviving P. falciparum (%) |
|---|---|
| 0 (Control) | 100 % |
| 10 | 85 % |
| 20 | 50 % (IC₅₀ Value) |
| 40 | 12 % |
| 80 | 2 % |
๐ Next Steps
More Biology Hub Pages !
❓ In case of any doubt, Chat Directly: ๐ฌ Ask Your Doubt on WhatsApp
Share with the Friends ๐





Comments
Post a Comment